BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26744903)

  • 1. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
    Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
    Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.
    McGill JB
    Postgrad Med; 2009 Jan; 121(1):46-58. PubMed ID: 19179813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes.
    Omar BA; Liehua L; Yamada Y; Seino Y; Marchetti P; Ahrén B
    Diabetologia; 2014 Sep; 57(9):1876-83. PubMed ID: 24939431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
    Ahrén B; Foley JE
    Int J Clin Pract Suppl; 2008 Mar; (159):8-14. PubMed ID: 18269436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.
    Ueberberg S; Jütte H; Uhl W; Schmidt W; Nauck M; Montanya E; Tannapfel A; Meier J
    Diabetes Obes Metab; 2016 Dec; 18(12):1253-1262. PubMed ID: 27545110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
    Traub S; Meier DT; Schulze F; Dror E; Nordmann TM; Goetz N; Koch N; Dalmas E; Stawiski M; Makshana V; Thorel F; Herrera PL; Böni-Schnetzler M; Donath MY
    Cell Rep; 2017 Mar; 18(13):3192-3203. PubMed ID: 28355570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VMP1-related autophagy induced by a fructose-rich diet in β-cells: its prevention by incretins.
    Maiztegui B; Boggio V; Román CL; Flores LE; Zotto HD; Ropolo A; Grasso D; Vaccaro MI; Gagliardino JJ
    Clin Sci (Lond); 2017 Apr; 131(8):673-687. PubMed ID: 28188238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
    Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
    Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion.
    Robson-Doucette CA; Sultan S; Allister EM; Wikstrom JD; Koshkin V; Bhattacharjee A; Prentice KJ; Sereda SB; Shirihai OS; Wheeler MB
    Diabetes; 2011 Nov; 60(11):2710-9. PubMed ID: 21984579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells.
    Augstein P; Naselli G; Loudovaris T; Hawthorne WJ; Campbell P; Bandala-Sanchez E; Rogers K; Heinke P; Thomas HE; Kay TW; Harrison LC
    Diabetes Res Clin Pract; 2015 Dec; 110(3):291-300. PubMed ID: 26515908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 as a treatment option for type 2 diabetes and its role in restoring beta-cell mass.
    Gallwitz B
    Diabetes Technol Ther; 2005 Aug; 7(4):651-7. PubMed ID: 16120042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.